Publications & Newsletters
Top news stories from AMA Morning Rounds®: Week of May 25 - 29, 2020
The news: 80 mill. babies missing vaccines, CDC guidance on antibody tests, study on asymptomatic COVID-19 patients, prescription drug supply, Dr. Harris op-ed
COVID-19 casts new light on an old problem: Drug shortages
National drug shortages are chronic. Learn about the root causes and efforts to these shortages, both in the long term and during the pandemic.
AMA praises DEA allowing increase in controlled substance production
During COVID-19, the number of patients requiring ventilators has resulted in huge spikes in demand for controlled substances.
COVID-19 policy recommendations for OUD, pain, harm reduction
The AMA provides policy recommendations to help guide policymakers reduce the stress of patients with an opioid use disorder and pain during the COVID-19 outbreak.
AMA, APhA, ASHP issue joint statement about COVID-19 medications
The joint statement is in response to reports of physicians and others prophylactically prescribing, medications currently identified as potential treatments for COVID-19.
Joint statement on ordering, prescribing or dispensing COVID-19 medications
Organizations highlight role physicians, pharmacists and health systems play in being just stewards of health care resources during times of emergency.
Explore the AMA's work to find solutions to national drug shortages that affect the health of patients.
Membership Moves Medicine™
- Free access to JAMA Network™ and CME
- Save hundreds on insurance
- Fight for physicians and patient rights